Exploring the intracellular pharmacokinetics of the 5-fluorouracil nucleotides during capecitabine treatment-Reference-Cited by-同舟云学术

Exploring the intracellular pharmacokinetics of the 5-fluorouracil nucleotides during capecitabine treatment

Published:2016-03-02 Issue:5 Volume:81 Page:949-957
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Derissen Ellen J. B.¹,Jacobs Bart A. W.¹,Huitema Alwin D. R.¹,Rosing Hilde¹,Schellens Jan H. M.²³,Beijnen Jos H.¹³

Affiliation:

1. Department of Pharmacy & Pharmacology; Antoni van Leeuwenhoek Hospital - The Netherlands Cancer Institute and MC Slotervaart; Louwesweg 6 1066 EC Amsterdam The Netherlands

2. Department of Clinical Pharmacology; The Netherlands Cancer Institute; Plesmanlaan 121 1066 CX Amsterdam The Netherlands

3. Science Faculty, Utrecht Institute for Pharmaceutical Sciences (UIPS), Division of Pharmaco-Epidemiology & Clinical Pharmacology; Utrecht University; P.O. Box 80082 3508 TB Utrecht The Netherlands

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12877/fullpdf

Reference25 articles.

1. Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue;Miwa;Eur J Cancer,1998

2. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients;Schüller;Cancer Chemother Pharmacol,2000

3. Mechanisms of action and modulation of fluorouracil;Grem;Semin Radiat Oncol,1997

4. 5-Fluorouracil derivatives: a patent review;Álvarez;Expert Opin Ther Pat,2012

5. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5′-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes;Peters;Cancer Res,1986

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) methods for the therapeutic drug monitoring of cytotoxic anticancer drugs: An update;Journal of Chromatography B;2024-02

2. Predictive factors for the development of capecitabine-induced hand-foot syndrome: a retrospective observational cohort study;Annals of Medicine & Surgery;2023-11-07

3. Physiologically Based Pharmacokinetic Modeling for Prediction of 5-FU Pharmacokinetics in Cancer Patients with Hepatic Impairment After 5-FU and Capecitabine Administration;Pharmaceutical Research;2023-08-23

4. The novel anti-cancer fluoropyrimidine NUC-3373 is a potent inhibitor of thymidylate synthase and an effective DNA-damaging agent;Cancer Chemotherapy and Pharmacology;2023-03-31

5. In vitro co-culture systems of hepatic and intestinal cells for cellular pharmacokinetic and pharmacodynamic studies of capecitabine against colorectal cancer;Cancer Cell International;2023-01-31